EMLA (VersaHD)
Overview
The Elekta Medical Linear Accelerator (EMLA) Versa HD is an advanced linear accelerator system designed to improve patient care and treat a broader spectrum of cancers. It offers high-precision beam shaping and tumor targeting, capable of delivering radiation doses three times faster than previous generation Elekta linear accelerators. Versa HD provides clinicians with the flexibility to deliver conventional therapies for a wide range of tumors throughout the body, while also enabling treatment of highly complex cancers requiring extreme targeting precision. The system integrates with Agility 160-leaf multileaf collimator (MLC) for high-definition, high-speed beam shaping over a versatile 40×40 cm field. It supports advanced therapies such as stereotactic radiosurgery (SRS), stereotactic radiotherapy (SRT), and volumetric modulated arc therapy (VMAT).
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- High-precision beam shaping and tumor targeting
- Rapid radiation dose delivery (up to three times faster than previous models)
- Agility 160-leaf multileaf collimator (MLC) for high-definition beam shaping
- Support for advanced therapies: SRS, SRT, VMAT
- 4D image-guided radiotherapy (IGRT) for visualizing small and moving tumors
- Motion management with advanced 4D image guidance and Active Breathing Coordinator (ABC) system
- Customizable, disease-specific configurations
- Real-time remote system monitoring
- Low environmental impact and energy consumption design
- High-definition dynamic radiosurgery (HDRS)
Use Cases
- External beam radiation therapy (EBRT) for various cancers
- Treatment of highly complex cancers requiring extreme targeting precision
- Stereotactic radiosurgery (SRS) for brain tumors
- Stereotactic body radiation therapy (SBRT) for extracranial tumors
- Treatment of functional disorders like trigeminal neuralgia
- Curative and palliative intent EBRT for adult and pediatric patients with primary benign and malignant tumors and metastases
Details
| Category | Oncology AI, Radiology & Imaging AI, Surgical AI |
| Pricing | Unknown |
| Deployment | On-premise |
| Compliance | |
| BAA Available | Unknown |
| HIPAA Compliant | Unknown |
| FDA Status | Cleared AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | Nuclear Medicine, Oncology, Radiology |
FDA clearance history
This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.
| Decision date | Number | Name as listed by FDA |
| 2026-01-15 | K252188 510(k) | EMLA (VersaHD) |
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate EMLA (VersaHD)
Videos
Product demos, reviews, and walkthroughs for EMLA (VersaHD).
No FAQs available yet for this tool.









